Hudson Bay Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.4M Hold
484,000
0.1% 151
2025
Q4
$46.1M Sell
484,000
-1,906
-0.4% -$187K 0.15% 124
2025
Q3
$47.4M Buy
485,906
+1,906
+0.4% +$197K 0.16% 107
2025
Q2
$52M Buy
+484,000
New +$49M 0.18% 100
2020
Q1
Sell
-525,000
Closed -$23.7M 504
2019
Q4
$23.7M Buy
525,000
+175,000
+50% +$7.32M 0.53% 31
2019
Q3
$14.2M Sell
350,000
-500,000
-59% -$21.2M 0.39% 50
2019
Q2
$36.5M Buy
+850,000
New +$32.7M 0.84% 21
2015
Q2
Sell
-200,000
Closed -$3.55M 225
2015
Q1
$3.55M Buy
+200,000
New +$3.16M 0.09% 119

Other funds holding BSX

Hudson Bay Capital Management's BSX Position: Q1 2026 in Review

Hudson Bay Capital Management held its Boston Scientific (BSX) position steady in Q1 2026 at 484,000 shares worth $30.4M. The position accounts for 0.1% of the portfolio, ranked #151.

Hudson Bay Capital Management first reported a position in BSX in Q1 2015 and has held it in 8 quarters since. The position peaked at $52M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Hudson Bay Capital Management held 484,000 shares of Boston Scientific worth $30.4M as of Q1 2026.
  • Hudson Bay Capital Management left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.1% of Hudson Bay Capital Management's portfolio in Q1 2026, its #151 holding.
  • Hudson Bay Capital Management first reported a position in Boston Scientific in Q1 2015 and has held it in 8 quarters since.
  • Hudson Bay Capital Management's Boston Scientific position peaked at $52M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.